Back to search

Article

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway

2024-07-19

Abstract excerpt

<title>Abstract</title> <p>Rosacea is a chronic inflammatory skin disease characterized by facial erythema and telangiectasia. Despite ongoing research, the pathogenesis of rosacea remains incompletely understood, and current therapies are not entirely satisfactory. The JAK/STAT signaling pathway plays an essential role in immunoregulation, inflammation, and neurovascular regulation. Inhibition of the JAK/STAT pa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
982acf11-3a64-5a57-be2d-31e36cd5ce4b
DOI
10.21203/rs.3.rs-4645719/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathwayDOI 10.21203/rs.3.rs-4645719/v1
Select a neighboring publication to make it the new centre.